PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Am J Clin Nutr. Author manuscript; available in PMC Oct 1, 2009.
Published in final edited form as:
PMCID: PMC2574424
NIHMSID: NIHMS57310
Nut Consumption and Risk of Heart Failure in the Physicians’ Health Study I
Luc Djoussé,1 Tamara Rudich,1 and J. Michael Gaziano.1,2
1 Divisions of Aging, Preventive Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
2, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Correspondence: Luc Djoussé, MD, MPH, DSc, FAHA, Division of Aging, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, 1620 Tremont St, 3rd floor; Boston MA 02120, Tel. (617) 525-7591; Fax. (617) 525-7739; E-mail. ldjousse/at/rics.bwh.harvard.edu
Background
Heart failure is highly prevalent among older adults and is associated with high cost and societal burden. While previous studies have reported beneficial effects of dietary factors on heart failure predictors, no previous study has examined whether frequent consumption of nuts is associated with a lower risk of heart failure in a large prospective cohort.
Objective
To examine the association between nut consumption and incident heart failure and determine whether such relation is modified by overweight/obesity.
Design
Prospective cohort study of 20,976 participants from the Physicians’ Health Study I. Nut consumption was assessed using a simple abbreviated food questionnaire and self-reported heart failure was ascertained by follow-up questionnaires. We used Cox regression to estimate relative risks of heart failure.
Results
After an average follow-up of 19.6 years, 1,093 new cases of heart failure occurred. Nut consumption was not associated with the risk of developing heart failure in this cohort: multivariable adjusted hazard ratios (95% CI) were 1.0 (reference), 0.98 (0.83–1.15), 1.06 (0.89–1.27), and 1.014–1.22) for nut consumption of <1, 1, and 2+ servings per week, respectively (p for linear trend 0.64). The lack of a meaningful relation between nut intake and incident heart failure was seen in both lean and overweight/obese people (p for interaction 0.96).
Conclusion
Our data do not provide evidence for an association between nut consumption and incident heart failure in US male physicians. However, our data cannot rule out possible benefits of nut consumption on subtypes of heart failure not prevalent in this cohort.
Keywords: Diet, epidemiology, heart failure, nut consumption
Heart failure is a condition that could result from heterogeneous factors including myocardial damage, heart valve pathology, dysregulation in volume homeostasis, hormonal changes, etc. It is the leading cause of hospitalization among elderly and is associated with higher costs. At age 40 y, it is estimated that 1 in every 5 adults will develop heart failure during the remaining life time(1). Despite advances in medical and surgical management of heart failure, mortality after onset of heart failure remains high. Thus, underscoring the importance of primary prevention of this disease. Several predictors of heart failure can be influenced by modifiable lifestyle factors. For example, healthy diet, exercise, not smoking, and maintaining healthy weight have been shown to favorably influence heart failure risk factors including coronary artery disease(26), diabetes(79;911), and hypertension(12;13). Among dietary factors, nuts are low in sodium and also contain a variety of nutrients including mono- and polyunsaturated fatty acids, minerals such as magnesium and potassium, fiber, antioxidants, and vitamins with beneficial influence on blood pressure. Nut consumption has been previously associated with improved blood pressure(1418), lower risk of diabetes(19), weight loss(20), and lower risk of sudden death/coronary heart disease death(21). However, it is not known whether consumption of nuts is associated with a lower risk of heart failure. The current project sought to prospectively assess whether nut consumption was associated with a lower risk of heart failure among US male physicians.
Study population
We used data from the Physicians’ Health Study (PHS) I which was a randomized, double-blind, placebo-controlled trial designed to study low-dose aspirin and beta-carotene for the primary prevention of cardiovascular disease and cancer. Detailed description of the PHS I has been published(22). Of the total 22,071 participants, we excluded 615 subjects because of missing data on nut consumption; 27 subjects with prevalent heart failure at the time of exposure assessment; and 453 people who died before collection of data on nut consumption or with missing covariates. Thus, a final sample of 20,976 participants was used for current analyses. Each participant signed an informed consent and the Institutional review Board at Brigham and Women’s Hospital approved the study protocol.
Nut consumption
We used an abbreviated food frequency questionnaire to obtain self-reported information on nut consumption at 12 months post-randomization (1983–1985). Participants were asked to report how often, on average, they have consumed nuts (small packet or 1 oz) during the past year (possible responses were “rarely/never”, “1–3/month”, “1/week”, “2–4/week”, “5–6/week”, “daily”, and “2+/day”). Due to limited number of subjects in the higher frequency categories, we combined the last 4 categories to obtain stable estimates as previously published(21). While the food frequency questionnaire was not validated in this cohort, it has been validated in several cohorts(2326).
Ascertainment of heart failure in the PHS
Ascertainment of endpoints including heart failure in the PHS has been achieved using self-reported information on follow-up questionnaires. A questionnaire was mailed to each participant every 6 months during the first year and has been mailed annually thereafter to obtain information on compliance with the intervention and the occurrence of new outcomes including heart failure. Detailed description of heart failure validation in the PHS using the Framingham criteria(27)has been published elsewhere(28).
Other variables
Information on atrial fibrillation, coronary artery disease, valvular heart disease, hypertension, and diabetes mellitus has been collected through self-reported annual follow-up questionnaires. Data on demographics, anthropometric, history of hypercholesterolemia, and selected foods such as fruits and vegetables; breakfast cereals; physical activity; and smoking; alcohol consumption were obtained at baseline (1982 –1983).
Statistical analyses
We classified each subject into one of the following categories of nut consumption: none, < 1 per week, 1 per week, and = 2 servings per week. We computed person-time of follow up from exposure assessment (12 months post-randomization) until the first occurrence of a) heart failure, b) death, or c) date of receipt of last follow-up questionnaire. We used Cox proportional hazard models to compute multivariable adjusted hazard ratios with corresponding 95% confidence intervals using subjects in the lowest category of nut consumption as the reference group. We assessed confounding by established risk factors for heart failure. The initial model only adjusted for age (5-year categories) and a final model also controlled for body mass index (BMI), smoking (never, former, and current smokers of 1–19 and 20+ cigarettes per day), exercise (none, up to 1, 2–4, and 5+ times per week), alcohol consumption (none, <1, 1–4, 5–7, and 8+ drinks/week), multivitamin use (never, past, and current), aspirin assignment, hypercholesterolemia, fruit and vegetable intake (<5, 5–6, 7–13, and 14+ servings pr week), and prevalent diabetes. Assumptions for proportional hazard models were tested (by including main effects and product terms of covariates and logarithmic transformed time factor) and were met (all p values >0.05). In a secondary analysis, we examined whether adiposity modified the association between nut intake and heart failure by using BMI of 25 kg/m2 as cut point to separate lean from overweight/obese subjects. We then conducted stratified analyses by adiposity status (BMI < 25 or = 25 kg/m2) and tested statistical interaction using a product term of nut consumption and adiposity variable in a hierarchical model. All analyses were completed using SAS, version 9.1 (SAS Institute, NC). Significance level was set at 0.05.
The baseline characteristics of 20,976 US male physicians according to nut consumption are presented in Table 1. The mean age of study participants was 54.6±9.4 years (range 40.7 to 87.1 y) at the time of nut consumption assessment. Of the total population, 36%, 24%, and 20% reported nut consumption with a frequency of <1 serving/week, 1 serving/week, and = 2 servings/week, respectively. Nut consumption was associated with a higher proportion of current drinkers; physical activity; breakfast cereal consumption; and with a lower proportion of current smokers and hypertension. During an average follow-up of 19.6 years, 1,093 new cases of heart failure were documented. From the lowest to the highest category of nut consumption, crude incidence rates for heart failure were 27.9, 25.3, 28.0, and 26.1 cases/10,000 person-years, respectively. There was no evidence for a statistically significant association between nut consumption and incident heart failure. Multivariable adjusted hazard ratios (95% CI) for heart failure were 1.0 (reference), 0.98 (0.83–1.15), 1.06 (0.89–1.27), and 1.01 (0.84–1.22) for nut consumption of <1 serving/week, 1 serving/week, and = 2 servings per week, respectively (p for linear trend 0.64, Table 2). In secondary analysis, nut consumption was not associated with incident heart failure in lean subjects (BMI < 25 kg/m2) [multivariable adjusted hazard ratios (95% CI) of 1.0 (reference), 0.96 (0.75–1.24), 1.11 (0.85–1.46), and 1.00 (0.75–1.32) from the lowest to the highest category of nut consumption, respectively, p for trend 0.70] or overweight and obese subjects [corresponding multivariable adjusted hazard ratios (95% CI) of 1.0 (reference), 0.98 (0.79–1.23), 1.03 (0.81–1.30), and 1.01 (0.78–1.31), respectively, p for trend 0.80]. P value for interaction between nut consumption and obesity status was 0.96.
Table 1
Table 1
Baseline characteristics of 20,976 US male physicians according to nut consumption*
Table 2
Table 2
Hazard ratios (95%CI) for heart failure according to nut consumption
In this prospective study, we demonstrated that nut consumption was not associated with incident heart failure in apparently healthy US male physicians. In addition, such relation was not modified by overweight/obesity status. To the best of our knowledge, this is the first large epidemiological study to evaluate whether nut consumption is associated with the risk of heart failure. The lack of an association between nut consumption and heart failure risk is contrary to our a priori hypothesis of a lower risk of heart failure with frequent nut consumption and merits some comments.
Our inability to further differentiate the type of heart failure (with and without preserved left ventricular function) or conditions leading to heart failure development in this study prevent us from examining the relationship between nut consumption and heart failure subtypes. In addition, we did not have detailed information on types of nuts consumed (i.e. cashews, almonds, hazelnuts, walnuts, almonds, etc) to assess the amounts of saturated, polyunsaturated, monounsaturated fatty acids, and other nutrients provided by nuts. For example, walnuts would have more omega-3 fatty acids than macadamias nuts, which would contain more monounsaturated fatty acids. In addition, we did not have data on the preparation of nuts such as salted, spiced, roasted, or raw nuts to examine the influence of the preparation method on the risk of heart failure. Since study participants were physicians, it is less likely that consumption of salted nuts was important in this population given the positive association between sodium intake and hypertension. It is possible that overall, nut consumption does not have a meaningful influence on the risk of heart failure. Alternatively, because of their medical knowledge, participants at risk of heart failure (those with diabetes, hypertension, coronary heart disease, or left ventricular dysfunction) may have been more likely to consume nuts given previous reports on beneficial effects of nut consumption on diabetes(19), weight control(20), coronary artery disease(21), or blood pressure(17;18). Such scenario would bias the association towards the null and be consistent with our data. With a single measurement of nut consumption at baseline, it is difficult to disentangle such hypothesis.
Additional limitations of our study include the inability to generalize of our findings to the general population since our participants consisted solely of male physicians who may have different lifestyle habits than the general population; the inability to account for changes in frequency of nut consumption over time; possible over- or underreporting of nut consumption; and the lack of data on other foods and energy intake in this population to account for confounding by other dietary factors. However, our study has major strengths including the large sample size, a 20-year follow up, and a standardized and comprehensive ascertainment of outcomes in this cohort.
In conclusion, our data do not provide evidence for an association between nut consumption and the risk of incident heart failure among US male physicians. However, given the heterogeneity of heart failure syndrome, the current study cannot rule out possible beneficial effects of nut consumption certain subtypes of heart failure (i.e. heart failure due to diabetic causes).
Acknowledgments
The Physicians’ Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, MD. Dr. Djoussé is Principal Investigator on a K01 HL-70444 from the National Heart, Lung, and Blood Institute, Bethesda, MD.
We are indebted to the participants in the PHS for their outstanding commitment and cooperation and to the entire PHS staff for their expert and unfailing assistance.
Footnotes
The authors have no conflict of interest to declare.
Author contribution
Study concept and design: Djoussé
Acquisition of data: Gaziano
Drafting of the manuscript: Djoussé
Critical revision of the manuscript for important intellectual content: Djoussé, Rudich, and Gaziano
Statistical analysis: Djoussé
Obtaining funding: Gaziano
1. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–72. [PubMed]
2. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16–22. [PubMed]
3. Djousse L, Pankow JS, Eckfeldt JH, et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2001;74:612–9. [PubMed]
4. Djousse L, Arnett DK, Carr JJ, et al. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the NHLBI Family Heart Study. Circulation. 2005;111:2921–6. [PubMed]
5. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52. [PubMed]
6. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation. 2006;114:160–7. [PubMed]
7. Liu S, Manson JE, Stampfer MJ, et al. A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health. 2000;90:1409–15. [PubMed]
8. Kochar J, Djousse L, Gaziano JM. Breakfast cereals and risk of type-2 diabetes in the Physicians' Health Study I. Obesity. 2007;15:3039–44. [PubMed]
9. Djousse L, Kochar J, Gaziano JM. Dietary factors and risk of heart failure: a systematic review. Curr Cardiovasc Risk Rep. 2007;1:330–334.
10. Krishnan S, Rosenberg L, Singer M, Hu FB, Djousse L, Cupples LA. Glycemic index, glycemic load, cereal fiber and risk of type 2 diabetes in U.S. black women. Arch Intern Med. 2007;167:2304–2309. [PubMed]
11. Djousse L, Biggs ML, Mukamal KJ, Siscovick D. Alcohol Consumption and Type 2 Diabetes Among Older Adults: The Cardiovascular Health Study. Obesity. 2007;15:1758–65. [PubMed]
12. Moore LL, Singer MR, Bradlee ML, et al. Intake of fruits, vegetables, and dairy products in early childhood and subsequent blood pressure change. Epidemiology. 2005;16:4–11. [PubMed]
13. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24. [PubMed]
14. Ferrara L, Raimondi S, d'Episcopo L, Guida L, Dello Russo A, Marotta T. Olive oil and reduced need for antihypertensive medications. Arch Intern Med. 2000;160:837–42. [PubMed]
15. Brancati FL, Appel LJ, Seidler AJ, Whelton PK. Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial. Arch Intern Med. 1996;156:61–7. [PubMed]
16. Myers VH, Champagne CM. Nutritional effects on blood pressure. Curr Opin Lipidol. 2007;18:20–4. [PubMed]
17. Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145:1–11. [PubMed]
18. Welty FK, Lee KS, Lew NS, Zhou JR. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med. 2007;167:1060–7. [PubMed]
19. Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002;288:2554–60. [PubMed]
20. Bes-Rastrollo M, Sabate J, Gomez-Gracia E, Alonso A, Martinez JA, Martinez-Gonzalez MA. Nut consumption and weight gain in a Mediterranean cohort: The SUN study. Obesity (Silver Spring) 2007;15:107–16. [PubMed]
21. Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med. 2002;162:1382–7. [PubMed]
22. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med. 1989;321:129–35. [PubMed]
23. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1114–26. [PubMed]
24. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65. [PubMed]
25. Stein AD, Shea S, Basch CE, Contento IR, Zybert P. Consistency of the Willett semiquantitative food frequency questionnaire and 24-hour dietary recalls in estimating nutrient intakes of preschool children. Am J Epidemiol. 1992;135:667–77. [PubMed]
26. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18:858–67. [PubMed]
27. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–15. [PubMed]
28. Djousse L, Gaziano JM. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation. 2007;115:34–9. [PubMed]